Clinical Trials Directory

Trials / Unknown

UnknownNCT02755207

Potential Diagnostic and Prognostic Value of microRNAs for the Patients of Acute Coronary Syndrome

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the potential diagnostic and prognosis value of circulating microRNAs compared with cTnI for suspected ACS patients at the emergency department (ED) and intensive care unit (ICU).

Detailed description

The present study is a single-center, prospective diagnostic study among patients presenting to the ED or ICU within 24 h of onset of chest pain suggestive of suspected ACS. We propose to construct the biobank of ACS and evaluate the potential diagnostic value of circulating microRNAs compared with cTnI for suspected ACS patients. All the patients are to be followed up for 6 months. Final diagnosis was made by an expert panel cardiologist, based on all available clinical information including cTnI measurements, ECG, coronary angiography, cardiac exercise tests and information from hospital discharge letters. The concentrations of microRNAs will be evaluated by quantitative reverse transcription PCR, using highly specific primers and hybridization probes.

Conditions

Timeline

Start date
2016-04-01
Primary completion
2020-05-01
Completion
2020-12-01
First posted
2016-04-28
Last updated
2020-02-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02755207. Inclusion in this directory is not an endorsement.

Potential Diagnostic and Prognostic Value of microRNAs for the Patients of Acute Coronary Syndrome (NCT02755207) · Clinical Trials Directory